Fadi El‐Atat

842 total citations
16 papers, 626 citations indexed

About

Fadi El‐Atat is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Fadi El‐Atat has authored 16 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pharmacology. Recurrent topics in Fadi El‐Atat's work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Diet and metabolism studies (3 papers). Fadi El‐Atat is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Diet and metabolism studies (3 papers). Fadi El‐Atat collaborates with scholars based in United States. Fadi El‐Atat's co-authors include James R. Sowers, Samy I. McFarlane, Sameer Stas, Ashish Aneja, Luther T. Clark, Jonathan Pena Castro, J. Thomas Bigger, John Shin, George L. Bakris and Nicole Simon and has published in prestigious journals such as Journal of the American Society of Nephrology, Endocrinology and Metabolism Clinics of North America and Current Diabetes Reports.

In The Last Decade

Fadi El‐Atat

14 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fadi El‐Atat United States 9 259 254 99 84 83 16 626
L. Romayne Kurukulasuriya United States 12 253 1.0× 202 0.8× 105 1.1× 81 1.0× 62 0.7× 21 609
Marco Versiero Italy 8 200 0.8× 277 1.1× 102 1.0× 94 1.1× 175 2.1× 12 656
R LEWANCZUK Canada 15 241 0.9× 247 1.0× 105 1.1× 35 0.4× 117 1.4× 19 614
L Luchetti Italy 5 452 1.7× 194 0.8× 190 1.9× 152 1.8× 87 1.0× 9 712
Alessandra Saldanha de Mattos Matheus Brazil 10 297 1.1× 181 0.7× 129 1.3× 75 0.9× 106 1.3× 22 667
Elli Stefanadi Greece 13 142 0.5× 232 0.9× 93 0.9× 102 1.2× 87 1.0× 17 567
L. A. Leiter Canada 9 181 0.7× 179 0.7× 68 0.7× 40 0.5× 133 1.6× 14 561
Maria Virginia Manzi Italy 16 168 0.6× 412 1.6× 79 0.8× 55 0.7× 106 1.3× 62 789
Juan García‐Puig Spain 17 307 1.2× 550 2.2× 60 0.6× 129 1.5× 140 1.7× 45 1.0k
Patrizio Tatti Italy 12 504 1.9× 509 2.0× 160 1.6× 50 0.6× 106 1.3× 31 941

Countries citing papers authored by Fadi El‐Atat

Since Specialization
Citations

This map shows the geographic impact of Fadi El‐Atat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi El‐Atat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi El‐Atat more than expected).

Fields of papers citing papers by Fadi El‐Atat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fadi El‐Atat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi El‐Atat. The network helps show where Fadi El‐Atat may publish in the future.

Co-authorship network of co-authors of Fadi El‐Atat

This figure shows the co-authorship network connecting the top 25 collaborators of Fadi El‐Atat. A scholar is included among the top collaborators of Fadi El‐Atat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi El‐Atat. Fadi El‐Atat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
El‐Atat, Fadi, et al.. (2011). A randomized pilot trial for aggressive therapeutic approaches in aspirin-resistant patients undergoing percutaneous coronary intervention.. PubMed. 23(1). 9–13. 5 indexed citations
2.
Clark, Luther T. & Fadi El‐Atat. (2007). Metabolic syndrome in African Americans: Implications for preventing coronary heart disease. Clinical Cardiology. 30(4). 161–164. 52 indexed citations
3.
McFarlane, Samy I., Jonathan Pena Castro, John Shin, et al.. (2005). Control of Blood Pressure and Other Cardiovascular Risk Factors at Different Practice Settings: Outcomes of Care Provided to Diabetic Women Compared to Men. Journal of Clinical Hypertension. 7(2). 73–80. 45 indexed citations
4.
El‐Atat, Fadi, Tatjana Rundek, James R. Sowers, & Samy I. McFarlane. (2005). Stroke prevention in diabetic and other high cardiovascular risk patients. Current Diabetes Reports. 5(3). 200–207. 5 indexed citations
5.
El‐Atat, Fadi, et al.. (2005). Cardiovascular disease in diabetes and the cardiometabolic syndrome: Focus on minority women. Current Diabetes Reports. 5(3). 208–213. 7 indexed citations
6.
El‐Atat, Fadi, et al.. (2005). An overview of the beneficial cardiovascular effects of thiazolidinediones. Therapy. 2(1). 113–119. 9 indexed citations
7.
El‐Atat, Fadi, et al.. (2005). An overview of the beneficial cardiovascular effects of thiazolidinediones. Therapy. 2(1). 113–119. 1 indexed citations
8.
El‐Atat, Fadi, Sameer Stas, Samy I. McFarlane, & James R. Sowers. (2004). The Relationship between Hyperinsulinemia, Hypertension and Progressive Renal Disease. Journal of the American Society of Nephrology. 15(11). 2816–2827. 160 indexed citations
9.
Stas, Sameer, Fadi El‐Atat, & James R. Sowers. (2004). Pathogenesis of Hypertension in Diabetes. Reviews in Endocrine and Metabolic Disorders. 5(3). 221–225. 28 indexed citations
10.
El‐Atat, Fadi, Samy I. McFarlane, James R. Sowers, & J. Thomas Bigger. (2004). Sudden cardiac death in patients with diabetes. Current Diabetes Reports. 4(3). 187–193. 39 indexed citations
11.
El‐Atat, Fadi, Samy I. McFarlane, & James R. Sowers. (2004). Diabetes, hypertension, and cardiovascular derangements: Pathophysiology and management. Current Hypertension Reports. 6(3). 215–223. 93 indexed citations
12.
McFarlane, Samy I., Fadi El‐Atat, Jonathan Pena Castro, et al.. (2004). Effects of sliding scale insulin use on glycemic control and length of stay in hospitalized patients with Type 2 diabetes mellitus. Therapy. 1(1). 81–85. 2 indexed citations
13.
McFarlane, Samy I., Fadi El‐Atat, Jonathan M. Castro, et al.. (2004). Effects of sliding scale insulin use on glycemic control and length of stay in hospitalized patients with Type 2 diabetes mellitus. Therapy. 1(1). 81–85.
14.
Castro, Jonathan Pena, Fadi El‐Atat, Samy I. McFarlane, Ashish Aneja, & James R. Sowers. (2003). Cardiometabolic syndrome: Pathophysiology and treatment. Current Hypertension Reports. 5(5). 393–401. 118 indexed citations
15.
El‐Atat, Fadi, Ashish Aneja, Samy I. McFarlane, & James R. Sowers. (2003). Obesity and hypertension. Endocrinology and Metabolism Clinics of North America. 32(4). 823–854. 58 indexed citations
16.
Muniyappa, Ranganath, Fadi El‐Atat, Ashish Aneja, & Samy I. McFarlane. (2003). The diabetes prevention program. Current Diabetes Reports. 3(3). 221–222. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026